Who Exports Isosorbide from India — 181 Suppliers Behind a $44.9M Market
India's isosorbide export market is supplied by 181 active exporters who collectively shipped $44.9M across 1,961 shipments. TORRENT PHARMACEUTICALS LTD leads with a 39.2% market share, followed by COHANCE LIFESCIENCES LIMITED and RUBICON RESEARCH PRIVATE LIMITED. The top 5 suppliers together control 82.2% of total export value, reflecting a concentrated market structure.
Top Isosorbide Exporters from India — Ranked by Export Value
TORRENT PHARMACEUTICALS LTD is the leading isosorbide exporter from India, holding a 39.2% share of the $44.9M market across 1,961 shipments from 181 exporters. The top 5 suppliers — TORRENT PHARMACEUTICALS LTD, COHANCE LIFESCIENCES LIMITED, RUBICON RESEARCH PRIVATE LIMITED, RA CHEM PHARMA LIMITED, ZYDUS LIFESCIENCES LIMITED — collectively control 82.2% of total export value, indicating a highly concentrated market. Individual shares are: TORRENT PHARMACEUTICALS LTD (39.2%), COHANCE LIFESCIENCES LIMITED (19.5%), RUBICON RESEARCH PRIVATE LIMITED (10.9%), RA CHEM PHARMA LIMITED (7.3%), ZYDUS LIFESCIENCES LIMITED (5.3%).
Top Isosorbide Exporters from India
Ranked by export value · 181 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $17.6M | 5 | 39.2% |
| 2 | COHANCE LIFESCIENCES LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $8.8M | 1 | 19.5% |
| 3 | RUBICON RESEARCH PRIVATE LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $4.9M | 1 | 10.9% |
| 4 | RA CHEM PHARMA LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $3.3M | 1 | 7.3% |
| 5 | ZYDUS LIFESCIENCES LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $2.4M | 6 | 5.3% |
| 6 | TORRENT PHARMACEUTICALS LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $1.7M | 3 | 3.7% |
| 7 | RUBICON RESEARCH LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $993.3K | 2 | 2.2% |
| 8 | PAR FORMULATIONS PRIVATE LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $987.3K | 1 | 2.2% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES LIMITED MONOTRATE 20 TABLETS (ISOSORBIDE MONONITMONOTRATE 10 TABLETS(ISOSORBIDE MONONITRMONOTRATE OD 25 TABLETS(ISOSORBIDE-5-MON | $482.6K | 1 | 1.1% |
| 10 | IND SWIFT LIMITED VASOTRATE 30 OD TABLET(ISOSORBIDE MONONIMONOTRATE 20 TABLETS (ISOSORBIDE MONONITMONOTRATE 10 TABLETS(ISOSORBIDE MONONITR | $404.6K | 1 | 0.9% |
| 11 | INVENTIA HEALTHCARE LIMITED NITROFIX SR 30 TAX INV NO: 712203414/13.03.2025 | $393.5K | 1 | 0.9% |
| 12 | MEDREICH LIMITED | $314.3K | 1 | 0.7% |
| 13 | MARKSANS PHARMA LIMITED | $246.3K | 1 | 0.5% |
| 14 | CADILA HEALTHCARE LIMITED OTHER-ISOSORBIDE MONONITRATE ER TABLETSUSP 60 MGISOSORBIDE MONONITRATE ER TABLETS USPISOSORBIDE DINITRATE TABLETS USP 40MG [1 | $238.5K | 4 | 0.5% |
| 15 | IND-SWIFT LIMITED | $200.3K | 1 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Isosorbide exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Torrent Pharmaceuticals Limited | Approved | Yes | Yes | Not verified | FDA warning letter issued on October 8, 2019, for CGMP violations at Indrad faci |
| Cohance Lifesciences Limited | Warning Letter, January 3 | Unknown | Unknown | Not verified | FDA warning letter issued on January 30, 2026, for CGMP violations at Medchal-Ma |
| Zydus Lifesciences Limited | Warning Letter, August 29 | Unknown | Unknown | Not verified | FDA warning letter issued on August 29, 2024. |
| Sun Pharmaceutical Industries Limited | Warning Letter, June 18, | Unknown | Unknown | Not verified | FDA warning letter issued on June 18, 2024. |
| Marksans Pharma Limited | Warning Letter, September | Unknown | Unknown | Not verified | FDA warning letter issued on September 23, 2019. |
| Rubicon Research Limited | Approved | Unknown | Unknown | Multiple | Multiple ANDA approvals from FDA. |
| Inventia Healthcare Limited | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found. |
| Ind-Swift Limited | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found. |
TransData Nexus reviewed the regulatory standing of 8 leading Isosorbide exporters from India. 2 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. 4 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Isosorbide sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research in India. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of active pharmaceutical ingredients (APIs) and formulations. The presence of these industry giants underscores Hyderabad's pivotal role in the pharmaceutical sector.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its extensive pharmaceutical manufacturing capabilities. Companies such as Alembic Pharmaceuticals, Zydus Lifesciences, and Torrent Pharmaceuticals are headquartered here, focusing on the production of APIs, finished formulations, and biopharmaceuticals. The region's well-established infrastructure and strategic location make it a key player in India's pharmaceutical exports.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceutical products. Sun Pharmaceutical Industries, headquartered in Mumbai, is among the largest pharmaceutical companies in India, with a significant presence in this region. The area's proximity to major ports facilitates efficient international distribution, reinforcing its status as a vital node in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, driven by favorable tax incentives and supportive government policies. The area hosts numerous pharmaceutical units, contributing to its reputation as a key player in the industry. The region's growth is further bolstered by its strategic location and infrastructure.
5Sourcing Recommendations
- Diversify Supplier Base: While major exporters like Torrent Pharmaceuticals and Zydus Lifesciences dominate the market, consider engaging with emerging manufacturers in regions like Hyderabad and Baddi to mitigate supply chain risks.
- Leverage Government Initiatives: Utilize the Assistance to Pharmaceutical Industry for Common Facilities (APICF) scheme, which provides grant-in-aid support for pharmaceutical clusters to create common infrastructure facilities, enhancing quality and productivity.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements, particularly when exporting to stringent markets like the United States and the European Union.
- Assess Logistics Infrastructure: Evaluate the logistical capabilities of manufacturing clusters, especially those in proximity to major ports like Mumbai, to optimize shipping times and costs.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Isosorbide exporters from India
Torrent Pharmaceuticals Limited — Torrent Pharma acquires three anti-diabetes brands from Boehringer Ingelheim
In December 2024, Torrent Pharmaceuticals announced the acquisition of three anti-diabetes brands—Cospiaq (empagliflozin), Cospiaq Met (empagliflozin + metformin), and Xilingio (empagliflozin + linagliptin)—from Boehringer Ingelheim International GmbH. - IMPACT: This acquisition is not expected to directly impact Isosorbide exports, as it focuses on expanding Torrent's anti-diabetes portfolio.
Impact: This acquisition is not expected to directly impact Isosorbide exports, as it focuses on expanding Torrent's anti-diabetes portfolio.
Zydus Lifesciences Limited — Zydus Lifesciences incorporates subsidiary in France to acquire Amplitude Surgical
In April 2025, Zydus Lifesciences announced the incorporation of a wholly owned subsidiary, Zydus MedTech (France) SAS, in France, through which it intends to acquire the equity shares of Amplitude Surgical SA. - IMPACT: This strategic move is aimed at enhancing Zydus's presence in the European market and is not anticipated to affect Isosorbide export activities.
Impact: This strategic move is aimed at enhancing Zydus's presence in the European market and is not anticipated to affect Isosorbide export activities.
Cohance Lifesciences Limited — Suven Pharmaceuticals rebrands as Cohance Lifesciences
The Ministry of Corporate Affairs approved the change of name from "Suven Pharmaceuticals Limited" to "Cohance Lifesciences Limited" with effect from May 7, 2025. - IMPACT: This rebranding reflects a strategic shift but does not directly influence Isosorbide export operations.
Impact: This rebranding reflects a strategic shift but does not directly influence Isosorbide export operations.
Common Questions — Isosorbide Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which isosorbide supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, TORRENT PHARMACEUTICALS LTD leads with 165 recorded shipments worth $17.6M. COHANCE LIFESCIENCES LIMITED (141 shipments) and RUBICON RESEARCH PRIVATE LIMITED (146 shipments) are also established high-volume exporters.
Q How many isosorbide manufacturers are there in India?
India has 181 active isosorbide exporters with a combined export market of $44.9M across 1,961 shipments to 102 countries. The top 5 suppliers hold 82.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for isosorbide from India?
Average FOB unit price: $2.75 per unit, ranging from $0.00 to $1758.33. Average shipment value: $22.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 181 verified Indian exporters of Isosorbide ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,961 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 102 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,961 Verified Shipments
181 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists